1. Phytopharmacology and Clinical Updates of Berberis Species Against Diabetes and Other Metabolic Diseases
   Tarun Belwal et al, 2020, Front. Pharmacol. CrossRef
2. The Effect of Natural Antioxidants in the Development of Metabolic Syndrome: Focus on Bergamot Polyphenolic Fraction
   Cristina Carresi et al, 2020, Nutrients CrossRef
3. Berberine chloride suppresses non-small cell lung cancer by deregulating Sin3A/TOP2B pathway in vitro and in vivo
   Jian Chen et al, 2020, Cancer Chemother Pharmacol CrossRef
4. Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota
   Ying Wang et al, 2021, Front. Endocrinol. CrossRef
5. Potencjalne możliwości wykorzystania berberyny w przeciwdziałaniu insulinooporności i w cukrzycy typu 2
   Michalina Mróz et al, 2021 CrossRef
6. The Effective Role of Natural Product Berberine in Modulating Oxidative Stress and Inflammation Related Atherosclerosis: Novel Insights Into the Gut-Heart Axis Evidenced by Genetic Sequencing Analysis
   Richard Y. Cao et al, 2021, Front. Pharmacol. CrossRef
7. Metabolic Syndrome-Related Kidney Injury: A Review and Update
   Lirong Lin et al, 2022, Front. Endocrinol. CrossRef
8. Association of higher plasma leptin levels with HOMA-IR index, high sensitivity C-reactive protein and glycolipid metabolism in patients with chronic schizophrenia: A multi-center cross-sectional study
   Zhiwei Liu et al, 2022, Front. Psychiatry CrossRef
9. The effects of berberine supplementation on cardiovascular risk factors in adults: A systematic review and dose-response meta-analysis
   Mohammad Zamani et al, 2022, Front. Nutr. CrossRef
10. Advances of berberine against metabolic syndrome-associated kidney disease: Regarding effect and mechanism
    Ya-Fei Liu et al, 2023, Front. Pharmacol. CrossRef
11. Alkaloids as Promising Agents for the Management of Insulin Resistance: A Review
    Ayoub Amssayef et al, 2023, CPD CrossRef
12. Insulin resistance/hyperinsulinemia: an important cardiovascular risk factor that has long been underestimated
    Serafino Fazio et al, 2024, Front. Cardiovasc. Med. CrossRef
13. Development and evaluation of berberine-loaded bigel for the treatment of hyperpigmentation on B16F10 melanoma cell line
    Bharti Mangla et al, 2024, Nanomedicine CrossRef
14. Effects of Berberis asiatica, Withania somnifera, and Their Combination on Body Weight in Streptozotocin-Nicotinamide-Induced Type 2 Diabetes in Wistar Rats
    Devkumar D Tiwari et al, 2024 CrossRef
15. Targeting insulin resistance: myricetin and isorhamnetin from Hardwickia binata , and luteolin from Hedysarum alpinum enhance glucose uptake and AMPK signaling in HepG2 cells
    Shiva Shankar Reddy Nimmala et al, 2024, Natural Product Research CrossRef